Neuroendocrine prostate cancer (clinical case)
G. A. KhakimovTashkent Pediatric Medical Institute; Tashkent city branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and RadiologyG. G. KhakimovaTashkent Pediatric Medical Institute; Tashkent city branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology; 4 Moscow Institute of Clinical Medicine N.V. Sklifosovsky, I.M. Sechenov First Moscow State Medical University (Sechenov University)Shatha F. DalloTashkent Pediatric Medical InstituteShakhnoz G. KhakimovaTashkent Pediatric Medical Institute; Moscow Research Oncology Institute P.A. Herzen – branch of the National Medical Research Center of RadiologyA. M. KhakimovTashkent city branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology
ABI
Abstract
Neuroendocrine prostate cancer is a rare and aggressive cancer with a poor prognosis. This type of cancer is often diagnosed at an advanced stage and exhibits rapid resistance to standard therapeutic methods. Taking into account the low occurrence of this phenomenon, a description of poorly differentiated neuroendocrine (small cell) prostate cancer with extremely aggressive forms is given.
Topics
Identifiers
Citations and references
Cited by 024 references
Metrics — AkademScholar · Coming soon